Wei Li | Gene Therapy | Research Excellence Award

Prof. Dr. Wei Li | Gene Therapy | Research Excellence Award

Department of Hematology, the First Affiliated Hospital of Zhengzhou University | China

Dr. Wei Li is an Associate Professor and Lab Director at the Department of Hematology, the First Affiliated Hospital of Zhengzhou University. He holds a PhD in Bioinformatics and completed postdoctoral training in clinical medicine. His research centers on erythroid development, hematological malignancies, and disease genomics, with a strong emphasis on genetic mechanisms underlying red cell disorders and cancer. Dr. Li has published 17 peer-reviewed articles in leading journals such as Blood and Journal of Hematology & Oncology, and has an H-index of 22. He leads multiple national research projects, serves as Associate Editor of the Journal of Translational Medicine, and maintains international collaborations, notably with the New York Blood Center.

Citation Metrics (Scopus)

3000
2000
1000
100
0

Citations
1,394

Documents
63

h-index
21

Citations

Documents

h-index


View Scopus Profile
View Orcid Profile

Featured Publications

Yuhui Sun | Gene Therapy | Excellence in Research

Prof. Dr. Yuhui Sun | Gene Therapy | Excellence in Research

Huazhong University of Science and Technology | China

Prof. Dr. Yuhui Sun is a Professor at Huazhong University of Science and Technology, China. He received his Ph.D. from Shanghai Jiao Tong University and conducted postdoctoral research at the University of Cambridge in Professor Peter F. Leadlay’s group. He served as a Professor at Wuhan University before joining HUST. His research focuses on microbial natural product discovery, biosynthesis, and the development of advanced genetic and genome-editing tools, particularly CRISPR-Cas9–based base editors. Professor Sun has led eight major national and provincial research projects, published 69 SCI-indexed papers with an H-index of 25 and over 1,900 citations, authored a Springer Nature book chapter, and holds nine international and Chinese patents. He has extensive industry collaboration experience, serves on multiple international editorial boards, and is a Fellow of the Royal Society of Chemistry (UK). Internationally recognized for elucidating complex biosynthetic mechanisms and creating hybrid microbial medicines, he has also developed widely adopted genome-editing technologies shared with over 80 research groups worldwide.

Citation Metrics (Scopus)

2400
1800
1200
  600
  0

Citations
2,070

Documents
72

h-index
27

Citations

Documents

h-index


View Scopus Profile
View Orcid Profile

Featured Publications